News
Why an HIV patient advocacy group is suing the Trump administration over a Biden administration legal settlement with Gilead ...
The largest group of Black physicians, thought leaders, and celebrities were in one room to have a needed discussion about HIV.
With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...
On July 16, 49 attorneys general (AGs) announced that they joined a $202 million settlement with Gilead Sciences, Inc. (Gilead). Previously ...
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the top cheap pharmaceutical stocks to buy now. Morgan Stanley analyst Terence ...
An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...
7d
GlobalData on MSNGilead wins positive European approval opinion for twice-yearly HIV injectionThe European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...
Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...
8h
Medpage Today on MSNThe Future of ART Regimens for HIV Is in Long-Acting AgentsRecent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...
Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate settlement with Gilead Sciences, Inc. over an illegal kickback scheme to ...
7h
Investor's Business Daily on MSNGilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?Gilead Sciences GILD will announce second quarter results on Thursday. It would have to go a ways to top its Q1 earnings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results